[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:shigella":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Shigella",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07049159","Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old",[11],"Phase 2","RECRUITING","2026-08-26T02:18:02.701182Z","2026-05-05T02:43:27.612875Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07205926","First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults",[19],"Phase 1","2026-08-26T02:18:33.598205Z","2026-04-29T02:57:57.083517Z",[],[]]